Haron, D., Phillips, I., Harrow, S., Evans, T., MacLennan, K., Campbell, S., . . . Stares, M. (2024). 159 Outcomes of thoracic radiotherapy for oligoprogression after a response to Pembrolizumab in patients with advanced Non-Small Cell Lung Cancer. Lung Cancer (01695002), 190, N.PAG. https://doi.org/10.1016/j.lungcan.2024.107720
Chicago Style (17th ed.) CitationHaron, Dhania, Iain Phillips, Stephen Harrow, Tamasin Evans, Kirsty MacLennan, Sorcha Campbell, Melanie Mackean, Colin Barrie, and Mark Stares. "159 Outcomes of Thoracic Radiotherapy for Oligoprogression After a Response to Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer." Lung Cancer (01695002) 190 (2024): N.PAG. https://doi.org/10.1016/j.lungcan.2024.107720.
MLA (9th ed.) CitationHaron, Dhania, et al. "159 Outcomes of Thoracic Radiotherapy for Oligoprogression After a Response to Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer." Lung Cancer (01695002), vol. 190, 2024, p. N.PAG, https://doi.org/10.1016/j.lungcan.2024.107720.